CHXCART-01

N/A

Report date: 2025/04/08 17:08:05

Base Information

Drug NameCHXCART-01
Drug Alias NameCHXCART01CHXCART-01
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionB-lymphocyte antigen CD19 modulatorsT lymphocyte replacements
TargetsB-lymphocyte antigen CD19
Therapy Area/IndicationsLymphoma, B-CellPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesHong Kong Children'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesHong Kong Children'S Hospital
Inactive CompaniesN/A
Active IndicationsLymphoma, B-CellPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A